Effectiveness of the use of DAFS-25 in the Standard Hepatitis Treatment Regimen for Dogs

Abstract

The article provides a study on the effectiveness of the drug DAFS-25 in the standard hepatitis treatment regimen for dogs. The study was conducted in a veterinary clinic «Alabai», Astrakhan, based on the treatment of dogs of the Caucasian wolfhound breed from Kangly kennel. Key indicators of liver status in dogs were taken in the study: alkaline phosphatase (ALP), ALT, AST, ALB (albumin), (TB) total bilirubin, (TP) total protein; in the process of treatment, based on the results of the biochemical rapid analyzer Seamaty 120VP, animals were divided into three groups (one control and two experimental groups) by analyzing their state. Fifteen dogs aged 3-6 were reviewed in the study, the average weight of animals was 65 kg. Biochemical analysis was carried out at the beginning of the study, on the twentieth day and after the end of therapy. The standard treatment regimen was used in the control group and the drug DAFS-25 was added into the standard treatment regimen of experimental groups at a dose of 1.6 mg/kg (104 mg/head) in the second group and 4.8 mg/kg (312 mg/head) in the third group.